Skip to main content
SpringerLink
Log in

Indirect costs far outweigh treatment costs in RA

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Indirect costs far outweigh treatment costs in RA. Pharmacoecon. Outcomes News 318, 3–4 (2001). https://doi.org/10.1007/BF03280397

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03280397

Keywords

Search

Navigation